ID

32691

Description

Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data:  Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis

Keywords

  1. 11/12/18 11/12/18 -
  2. 11/12/18 11/12/18 -
Copyright Holder

GSK group of companies

Uploaded on

November 12, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Estimation of Dose Proportionality of Darapladib - 107038

Pharmacokinetics (Blood)

Administrative data
Description

Administrative data

Dosing date
Description

Dosing date

Data type

date

Dosing time
Description

Dosing time

Data type

time

Predose
Description

Predose

Actual date
Description

Actual date

Data type

date

Actual time
Description

Actual time

Data type

time

Similar models

Pharmacokinetics (Blood)

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative data
Dosing date
Item
Dosing date
date
Dosing time
Item
Dosing time
time
Item Group
Predose
Actual date
Item
Actual date
date
Actual time
Item
Actual time
time

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial